NCT05272241Recruiting
Registry of Asthma Characterization and Recruitment 3 (RACR3)
Registry of Asthma Characterization and Recruitment 3 (RACR3) (CAUSE-02)
Source: ClinicalTrials.gov · Last updated 21 Aug 2026
Brief summary (registry, in English)
This is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future DAIT NIAID-sponsored Childhood Asthma in Urban Settings (CAUSE) studies.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1500 (estimated)
- First submitted
- 28 Feb 2022
- Start date
- 6 May 2022
- Primary completion date
- May 2027
- Lead sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Diseases
- Asthma
- NCT number
- NCT05272241
What you commit to
- Study type: Observational
- Planned participants: 1500
- From 6 May 2022 to the primary completion date, May 2027
- 7 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- Past or current medical problems or findings from physical examination or laboratory testing, which, in the opinion of the investigator, may pose additional risks from participation in the study, may interfere with the participant's ability to comply with study requirements or that may affect the quality or interpretation of the data obtained from the study
- Participants who are pregnant or lactating will not be excluded or discontinued from the study, but will not undergo any procedures that are prohibited during pregnancy per the Childhood Asthma in Urban Settings 02 (CAUSE-02) Registry for Asthma Characterization and Recruitment 3 (RACR3) Manual of Procedures (MOP)(e.g., allergen skin testing, spirometry) during the pregnancy.
- Potential participants may be reassessed as outlined in the Protocol CAUSE-02 MOP.
Other
- Participant does not speak English or Spanish and/or guardian does not speak English or Spanish
- Participant does not have access to a phone, either personal or public, with regularity that could be used for scheduling and safety follow-up
Who the study is looking for
- Participant is either:
- At least 18 years old, willing and able to provide informed consent at the time of enrollment
- Under the age of 18, accompanied by a legal guardian who is willing and able to provide informed consent at the time of enrollment
- Participant has a primary place of residence within the Office of Management and Budget (OMB)-defined Metropolitan Statistical Area (MSA)
Sex: All · Accepts healthy volunteers
Sites (7)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Children's Hospital Colorado: Allergy Program Coordinator of this site? Confirm its status | Aurora | United States | Recruiting |
| Boston Children's Hospital: Department of Immunology Coordinator of this site? Confirm its status | Boston | United States | Not yet recruiting |
| Ann & Robert H. Lurie Children's Hospital of Chicago: Division of Allergy and Immunology Coordinator of this site? Confirm its status | Chicago | United States | Recruiting |
| Cincinnati Children's Hospital Medical Center: Asthma Center Coordinator of this site? Confirm its status | Cincinnati | United States | Recruiting |
| Columbia University Medical Center: Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine Coordinator of this site? Confirm its status | New York | United States | Not yet recruiting |
| Icahn School of Medicine at Mount Sinai: Division of Clinical Immunology, Immunology Institute Coordinator of this site? Confirm its status | New York | United States | Recruiting |
| Children's National Medical Center: Inner City Asthma Consortium (ICAC) Clinical Research Site Coordinator of this site? Confirm its status | Washington D.C. | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.